Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Lieven Annemans
Profile
Projects
Publications
Activities
482
Results
2022
Cost-effectiveness of exercise referral schemes : a systematic review of health economic studies
Amber Werbrouck
Nick Verhaeghe
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF PUBLIC HEALTH
2022
Cost-effectiveness of telemonitoring patients with cardiac implantable electronic devices : a systematic review
Sarah Raes
Ruben Willems
Lieven Annemans
C3
Conference
2022
Frequency of family meals and food consumption in families at high risk of type 2 diabetes : the Feel4Diabetes-study
Greet Cardon
Flore De Vylder
Ruben Willems
Lieven Annemans
Vicky Van Stappen
Nele Huys
A1
Journal Article
in
EUROPEAN JOURNAL OF PEDIATRICS
2022
How to pay for telemedicine : a comparison of ten health systems
Sarah Raes
Jeroen Trybou
Lieven Annemans
A1
Journal Article
in
HEALTH SYSTEMS & REFORM
2022
Last year of life of adults with congenital heart diseases : causes of death and patterns of care
Ruben Willems
Katya De Groote
Julie De Backer
Lieven Annemans
Michèle de Hosson
A1
Journal Article
in
EUROPEAN HEART JOURNAL
2022
Oral healthcare delivery in institutionalised older people : a health‐economic evaluation
Amber Werbrouck
Lieven Annemans
Barbara Janssens
Nick Verhaeghe
A1
Journal Article
in
GERODONTOLOGY
2022
2021
An early health technology assessment of 3D anatomic models in pediatric congenital heart surgery : potential cost-effectiveness and decision uncertainty
Philip Tack
Ruben Willems
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
2021
Cost-effectiveness analysis of a school- and community-based intervention to promote a healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe : the Feel4Diabetes-study
Ruben Willems
Ruben Brondeel
Greet Cardon
Lieven Annemans
A1
Journal Article
in
PREVENTIVE MEDICINE
2021
Different levels of care for follow-up of adults with congenital heart disease : a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits
Ruben Willems
Katya De Groote
Julie De Backer
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF HEALTH ECONOMICS
2021
Disease prevention and health promotion in Flanders : health economic evidence to support healthcare decision making
Amber Werbrouck
Lieven Annemans
Dissertation
2021
Do custom 3D-printed revision acetabular implants provide enough value to justify the additional costs? The health-economic comparison of a new porous 3D-printed hip implant for revision arthroplasty of Paprosky type 3B acetabular defects and its closest alternative
Philip Tack
Jan Victor
Paul Gemmel
Lieven Annemans
A1
Journal Article
in
ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH
2021
Influenza vaccination in patients with congenital heart disease in the pre-COVID-19 era : coverage rate, patient characteristics, and outcomes
Ruben Willems
Michèle de Hosson
Lieven Annemans
Julie De Backer
Katya De Groote
A1
Journal Article
in
CANADIAN JOURNAL OF CARDIOLOGY
2021
Provision of palliative care to adults with congenital heart disease at the end of life
Ruben Willems
Michèle de Hosson
Lieven Annemans
Julie De Backer
Katya De Groote
C3
Conference
2021
Step count associations between adults at risk of developing diabetes and their children : the Feel4Diabetes study
Greet Cardon
Marieke De Craemer
Vicky Van Stappen
Nele Huys
Lieven Annemans
Ruben Willems
A1
Journal Article
in
JOURNAL OF PHYSICAL ACTIVITY & HEALTH
2021
The value of medical 3D printing : hope versus hype
Philip Tack
Paul Gemmel
Lieven Annemans
Jan Victor
Dissertation
2021
2020
A health economic analysis of adult congenital heart disease care: exploration of the subsidiarity principle
Ruben Willems
Julie De Backer
Lieven Annemans
Dissertation
2020
A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium
Amber Werbrouck
Nick Verhaeghe
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2020
A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer
Elise De Bleser
Ruben Willems
Karel Decaestecker
Lieven Annemans
Aurélie De Bruycker
Valerie Fonteyne
Nicolaas Lumen
Gert De Meerleer
Piet Ost
Renée Bultijnck
A1
Journal Article
in
CANCERS
2020
Appropriateness of end-of-life care in people dying with dementia : applying quality indicators on linked administrative databases
Tinne Smets
Luc Deliens
Lieven Annemans
Joachim Cohen
A1
Journal Article
in
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION
2020
Belgian multicentre study on lumbar spine imaging : radiation dose and cost analysis : evaluation of compliance with recommendations for efficient use of medical imaging
Bieke De Roo
Lieven Annemans
Klaus Bacher
Koenraad Verstraete
A1
Journal Article
in
EUROPEAN JOURNAL OF RADIOLOGY
2020
Cost-utility analysis of lifestyle interventions to prevent type 2 diabetes in women with prior gestational diabetes
Amber Werbrouck
Lieven Annemans
Nick Verhaeghe
A1
Journal Article
in
EUROPEAN JOURNAL OF PUBLIC HEALTH
2020
Cost‐effectiveness of an in‐home respite care program to support informal caregivers of persons with dementia : a model‐based analysis
Sophie Vandepitte
Nele Van Den Noortgate
Nick Verhaeghe
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
2020
Creating the BELgian COngenital heart disease database combining administrative and clinical data (BELCODAC) : rationale, design and methodology
Ruben Willems
Lieven Annemans
Julie De Backer
Katya De Groote
A1
Journal Article
in
INTERNATIONAL JOURNAL OF CARDIOLOGY
2020
Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective : a cross-sectional study
Sophie Vandepitte
Lisa Van Wilder
Nele Van Den Noortgate
Sofie Verhaeghe
Jeroen Trybou
Lieven Annemans
A1
Journal Article
in
BMC GERIATRICS
2020
Long-term healthcare utilization, medical cost, and societal cost in adult congenital heart disease
Ruben Willems
Katya De Groote
Julie De Backer
Lieven Annemans
A1
Journal Article
in
CONGENITAL HEART DISEASE
2020
Methodology of the health economic evaluation of the Feel4Diabetes-study
Ruben Willems
Lore Pil
Vicky Van Stappen
Greet Cardon
Lieven Annemans
A1
Journal Article
in
BMC ENDOCRINE DISORDERS
2020
PA1 different levels of care for follow-up of adults with congenital heart disease
Ruben Willems
Katya De Groote
Julie De Backer
Lieven Annemans
C3
Conference
2020
The effectiveness and cost-effectiveness of an integrated osteoporosis care programme for postmenopausal women in Flanders : study protocol of a quasi-experimental controlled design
Caroline Verdonck
Lieven Annemans
Stefan Goemaere
Bruno Lapauw
Marie-Paule Doom
Liesbeth Borgermans
A1
Journal Article
in
ARCHIVES OF OSTEOPOROSIS
2020
The use of computer simulation modeling to estimate complications in patients with type 2 diabetes mellitus : comparative validation of the cornerstone diabetes simulation model
Lieven Annemans
A2
Journal Article
in
PHARMACOECONOMICS-OPEN
2020
Universal mental health interventions for children and adolescents : a systematic review of health economic evaluations
Amber Werbrouck
Nick Verhaeghe
Lieven Annemans
A1
Journal Article
in
APPLIED HEALTH ECONOMICS AND HEALTH POLICY
2020
2019
A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes : exploring uncharted territory
Amber Werbrouck
Nick Verhaeghe
Lieven Annemans
A1
Journal Article
in
DIABETES RESEARCH AND CLINICAL PRACTICE
2019
Cost-effectiveness of oral care in institutionalized older people
Amber Werbrouck
Lieven Annemans
Barbara Janssens
Nick Verhaeghe
C3
Conference
2019
De impact van het gebruik van palliatieve thuiszorgondersteuning op de kwaliteit en de kosten van levenseindezorg : een gematchte cohortstudie op populatieniveau
Arno Maetens
Kim Beernaert
Kristof Faes
Lieven Annemans
Koen Pardon
Luc Deliens
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2019
Direct medical costs of pediatric congenital heart disease surgery in a Belgian university hospital
Ruben Willems
Philip Tack
Katrien Francois
Lieven Annemans
A2
Journal Article
in
WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY
2019
Effectiveness of an in-home respite care program to support informal dementia caregivers : a comparative study
Sophie Vandepitte
Nele Van Den Noortgate
Sofie Verhaeghe
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
2019
Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort : the Feel4Diabetes-study
Greet Cardon
Nele Huys
Vicky Van Stappen
Lieven Annemans
Ruben Willems
Samiah Shadid
A1
Journal Article
in
DIABETES RESEARCH AND CLINICAL PRACTICE
2019
Health economics of end-of-life care : the particular case of COPD and Alzheimer’s disease
Kristof Faes
Lieven Annemans
Dissertation
2019
Impact of palliative home care support on the quality and costs of care at the end of life : a population-level matched cohort study
Kim Beernaert
Kristof Faes
Lieven Annemans
Koen Pardon
Luc Deliens
A1
Journal Article
in
BMJ OPEN
2019
New insights in the costs and quality of life of patients after ischemic stroke : implications for heath care policy
Sarah Dewilde
Lieven Annemans
Dissertation
2019
Opinions of general and adult congenital heart disease cardiologists on care for adults with congenital heart disease in Belgium : a qualitative study
Ruben Willems
Julie De Backer
Lieven Annemans
A1
Journal Article
in
CARDIOLOGY IN THE YOUNG
2019
Outcomes research
Lieven Annemans
Bookchapter
in
Clinical pharmacy education,practice and research : clinical pharmacy, drug information, pharmacovigilance, pharmacoeconomics and clinical research
2019
Real-world healthcare utilization in adult congenital heart disease : a systematic review of trends and ratios
Ruben Willems
Amber Werbrouck
Julie De Backer
Lieven Annemans
A1
Journal Article
in
CARDIOLOGY IN THE YOUNG
2019
Real-world healthcare utilization in adult congenital heart disease : a systematic review of trends and ratios
Ruben Willems
Amber Werbrouck
Julie De Backer
Lieven Annemans
C3
Conference
2019
The impact of psychosocial support for informal caregivers of persons with dementia with a special focus on an in-home respite care program
Sophie Vandepitte
Lieven Annemans
Nele Van Den Noortgate
Dissertation
2019
2018
'Highest risk-highest benefit' strategy : a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
Lieven Annemans
A1
Journal Article
in
EUROPEAN HEART JOURNAL
2018
3D anatomic models in pediatric congenital heart surgery
Ruben Willems
Philip Tack
Lieven Annemans
C3
Conference
2018
A cost-utility analysis of a mental health promotion program in social economy companies in Flanders
Benedicte Deforche
Ilse De Bourdeaudhuij
Lieven Annemans
C3
Conference
2018
A school- and community-based intervention to promote healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe : design and implementation of the Feel4Diabetes-study
Greet Cardon
Lieven Annemans
A1
Journal Article
in
PUBLIC HEALTH NUTRITION
2018
Appropriateness of end-of-life care in people dying from COPD : applying quality indicators on linked administrative databases
Luc Deliens
Lieven Annemans
A1
Journal Article
in
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
2018
Cost-effectiveness of guideline adherence in coronary patients : results from the EUROASPIRE IV survey : a registry from the European Society of Cardiology
Delphine De Smedt
Lieven Annemans
Gui De Backer
Dirk De Bacquer
C3
Conference
2018
Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease : results from the EUROASPIRE IV survey
Delphine De Smedt
Lieven Annemans
Gui De Backer
Kornelia Kotseva
Johan De Sutter
Dirk De Bacquer
A1
Journal Article
in
INTERNATIONAL JOURNAL OF CARDIOLOGY
2018
Development of a prediction model for long-term quality of life in critically ill patients
Sandra Oeyen
Karel Vermeulen
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
A1
Journal Article
in
JOURNAL OF CRITICAL CARE
2018
Endovascular training using a simulation based curriculum is less expensive than training in the hybrid angiosuite
Heidi Maertens
Frank Vermassen
Bart Doyen
Liesbeth Desender
Isabelle Van Herzeele
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
2018
Factors associated with the caregivers' desire to institutionalize persons with dementia : a cross-sectional study
Sophie Vandepitte
Nele Van Den Noortgate
Sofie Verhaeghe
Lisa Van Wilder
Delphine De Smedt
Lieven Annemans
A1
Journal Article
in
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
2018
Health and budget impact of combined HIV prevention : first results of the BELHIVPREV model
Steven Callens
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2018
Health-related costs in a sample of premenopausal non-diabetic overweight or obese females in Antwerp region : a cost-of-illness analysis
Lieven Annemans
Nick Verhaeghe
A1
Journal Article
in
ARCHIVES OF PUBLIC HEALTH
2018
Hospital financing of ischaemic stroke : determinants of funding and usefulness of DRG subcategories based on severity of illness
Sarah Dewilde
Lieven Annemans
A1
Journal Article
in
BMC HEALTH SERVICES RESEARCH
2018
Long-term outcomes and quality of life in critically ill patients
Sandra Oeyen
Johan Decruyenaere
Lieven Annemans
Dissertation
2018
Osteopathic care for low back pain and neck pain : a cost-utility analysis
Nick Verhaeghe
Janne Schepers
Lieven Annemans
A1
Journal Article
in
COMPLEMENTARY THERAPIES IN MEDICINE
2018
Osteopathic care for spinal complaints : a systematic literature review
Nick Verhaeghe
Janne Schepers
Lieven Annemans
A1
Journal Article
in
PLOS ONE
2018
Resource use during the last 6 months of life of individuals dying with and of Alzheimer's disease
Kristof Faes
Joachim Cohen
Lieven Annemans
A1
Journal Article
in
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
2018
Resource use during the last six months of life among COPD patients : a population level study
Kristof Faes
Lieven Annemans
A1
Journal Article
in
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
2018
Strategies for newborn screening for cystic fibrosis : a systematic review of health economic evaluations
Amber Werbrouck
Nick Verhaeghe
Lieven Annemans
A1
Journal Article
in
JOURNAL OF CYSTIC FIBROSIS
2018
The association between children’s and parents’ co-TV viewing and their total screen time in six European countries : cross-sectional data from the Feel4diabetes-study
Julie Latomme
Vicky Van Stappen
Greet Cardon
Marieke De Craemer
Nele Huys
Lieven Annemans
Lore Pil
A1
Journal Article
in
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
2018
What is already known about costs and cost-effectiveness of prevention of type 2 diabetes in women with gestational diabetes?
Amber Werbrouck
Nick Verhaeghe
Lieven Annemans
C3
Conference
2018
2017
Applying quality indicators for administrative databases to evaluate end-of-life care for cancer patients In Belgium
Lieven Annemans
Luc Deliens
A1
Journal Article
in
HEALTH AFFAIRS
2017
Cost-effectiveness and budget effect analysis of a population-based skin cancer screening
Lore Pil
Isabelle Hoorens
Katrien Vossaert
Vibeke Kruse
Lieven Annemans
Lieve Brochez
A1
Journal Article
in
JAMA DERMATOLOGY
2017
Critically ill octogenarians and nonagenarians : evaluation of long-term outcomes, post-hospital trajectories and quality of life one year and seven years after ICU discharge
Sandra Oeyen
Joris Vermassen
Ruth Piers
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
A1
Journal Article
in
MINERVA ANESTESIOLOGICA
2017
Economic consequences of legal and illegal drugs : the case of social costs in Belgium
Delfine Lievens
Freya Vander Laenen
Nick Verhaeghe
Lieven Pauwels
Wim Hardyns
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF DRUG POLICY
2017
Economic evaluations of welfare interventions : from hurdles to implementation
Janne Schepers
Lieven Annemans
Dissertation
2017
Effectiveness and cost-effectiveness of an in-home respite care program in supporting informal caregivers of people with dementia : design of a comparative study
Sophie Vandepitte
Nele Van Den Noortgate
Sofie Verhaeghe
Lieven Annemans
C3
Conference
2017
Financial incentives for integrated care for people with chronic conditions in Belgium : a qualitative study within the CORTEXS research project
Nick Verhaeghe
Lieven Annemans
C3
Conference
2017
Fulfillment of administrative and professional obligations of hospitals and mission motivation of physicians
Jeroen Trybou
Paul Gemmel
Sebastian Desmidt
Lieven Annemans
A1
Journal Article
in
BMC HEALTH SERVICES RESEARCH
2017
Further approaches to reduce the cost of renal replacement therapy
Raymond Vanholder
Lieven Annemans
Norbert Lameire
Wim Van Biesen
A1
Journal Article
in
NATURE REVIEWS NEPHROLOGY
2017
Geïntegreerde zorg vraagt een geïntegreerde financiering
Nick Verhaeghe
Lieven Annemans
Bookchapter
in
Onbezorgd : naar een geïntegreerd gezondheidssysteem
2017
Methodological considerations in social cost studies of addictive substances : a systematic literature review
Nick Verhaeghe
Delfine Lievens
Lieven Annemans
Freya Vander Laenen
A1
Journal Article
in
FRONTIERS IN PUBLIC HEALTH
2017
Reducing the costs of chronic kidney disease while delivering quality health care : a call to action
Raymond Vanholder
Lieven Annemans
Norbert Lameire
Wim Van Biesen
A1
Journal Article
in
NATURE REVIEWS NEPHROLOGY
2017
The health-related social costs of alcohol in Belgium
Nick Verhaeghe
Delfine Lievens
Lieven Annemans
Freya Vander Laenen
A1
Journal Article
in
BMC PUBLIC HEALTH
2017
The insights of health and welfare professionals on hurdles that impede economic evaluations of welfare interventions
Janne Schepers
Jolien Plaete
Ilse De Bourdeaudhuij
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
2017
2016
3D-printing techniques in a medical setting : a systematic literature review
Philip Tack
Jan Victor
Paul Gemmel
Lieven Annemans
A1
Journal Article
in
BIOMEDICAL ENGINEERING ONLINE
2016
Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure
Lore Pil
Isabelle Hoorens
Katrien Vossaert
Lieve Brochez
Lieven Annemans
A1
Journal Article
in
PREVENTIVE MEDICINE
2016
Cost of renal replacement : how to help as many as possible while keeping expenses reasonable?
Raymond Vanholder
Norbert Lameire
Lieven Annemans
Wim Van Biesen
A1
Journal Article
in
NEPHROLOGY DIALYSIS TRANSPLANTATION
2016
Cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer
Lore Pil
Jeroen Trybou
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF INTERNAL MEDICINE
2016
Cost-effectiveness of population-based skin cancer screening
Isabelle Hoorens
Lore Pil
Katrien Vossaert
Lieven Annemans
Lieve Brochez
C3
Conference
2016
Costs of drugs for treatment of rheumatic diseases
Lieven Annemans
A2
Journal Article
in
RMD OPEN
2016
Delivering diabetes education through nurseled telecoaching : cost-effectiveness analysis
Lieven Annemans
A1
Journal Article
in
PLOS ONE
2016
Development of a prediction model for long-term quality of life in critically ill patients
Sandra Oeyen
Karel Vermeulen
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
C3
Conference
2016
Economic evaluations of pharmacogenetic and pharmacogenomic screening tests : a systematic review : second update of the literature
Lieven Annemans
A1
Journal Article
in
PLOS ONE
2016
Economic impact of integrated care models for patients with chronic diseases : a systematic review
Lieven Annemans
Nick Verhaeghe
Mirko Petrovic
Dominique Vandijck
A1
Journal Article
in
VALUE IN HEALTH
2016
Effectiveness and cost-effectiveness of an in-home respite care program in supporting informal caregivers of people with dementia : design of a comparative study
Sophie Vandepitte
Nele Van Den Noortgate
Sofie Verhaeghe
Lieven Annemans
A1
Journal Article
in
BMC GERIATRICS
2016
Effectiveness of pricing strategies on French fries and fruit purchases among university students : results from an on-campus restaurant experiment
Benedicte Deforche
Lieven Annemans
Ilse De Bourdeaudhuij
A1
Journal Article
in
PLOS ONE
2016
Effectiveness of respite care in supporting informal caregivers of persons with dementia : a systematic review
Sophie Vandepitte
Nele Van Den Noortgate
Sofie Verhaeghe
Caroline Verdonck
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
2016
Effectiveness of respite care to support informal caregivers of persons with dementia: a systematic review
Sophie Vandepitte
Nele Van Den Noortgate
Sofie Verhaeghe
Lieven Annemans
C3
Conference
2016
Effectiveness of supporting informal caregivers of people with dementia: a systematic review of randomized and non-randomized controlled trials
Sophie Vandepitte
Nele Van Den Noortgate
Sofie Verhaeghe
Kristof Faes
Lieven Annemans
A1
Journal Article
in
JOURNAL OF ALZHEIMERS DISEASE
2016
Health economic evaluations in the continuum of chronic disease prevention
Lore Pil
Lieven Annemans
Dissertation
2016
Interventions that increase the use of cancer screening : a systematic review
Jeroen Trybou
Lore Pil
Lieven Annemans
C3
Conference
2016
Le coût social du crime lié aux substances légales et illégales en Belgique : alcool, drogues illicites, tabac, médicaments pharmaceutiques
Freya Vander Laenen
Lieven Annemans
Delfine Lievens
Lieven Pauwels
Wim Hardyns
Nele Schils
Nick Verhaeghe
C3
Conference
2016
Longitudinal prediction model for long-term quality of life in critically ill patients
Sandra Oeyen
Karel Vermeulen
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
C3
Conference
2016
Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes : insights from EPICOR, an international study of current practice patterns
Lieven Annemans
A1
Journal Article
in
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
2016
Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching
Lieven Annemans
A1
Journal Article
in
DIABETIC MEDICINE
2016
Patient and provider acceptance of telecoaching in type 2 diabetes : a mixed-method study embedded in a randomised clinical trial
Heidi Buysse
Lieven Annemans
A1
Journal Article
in
BMC MEDICAL INFORMATICS AND DECISION MAKING
2016
Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes : an analysis of the EPICOR registry
Lieven Annemans
A2
Journal Article
in
OPEN HEART
2016
Preliminary cost-effectiveness assessment of 3D printed anatomic models for congenital heart diseases
Philip Tack
Lieven Annemans
C3
Conference
2016
Preventive landscape of skin cancer in Belgium : a clinical and health economical analysis
Isabelle Hoorens
Lieve Brochez
Lieven Annemans
Dissertation
2016
Resource use and health care costs of COPD patients at the end of life : a systematic review
Kristof Faes
Veerle De Frene
Joachim Cohen
Lieven Annemans
A1
Journal Article
in
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
2016
The impact of economic and noneconomic exchange on physicians' organizational attitudes: the moderating effects of the Chief Medical Officer
Jeroen Trybou
Paul Gemmel
Lieven Annemans
A1
Journal Article
in
HEALTH CARE MANAGEMENT REVIEW
2016
The potential health and economic effect of a Body Mass Index decrease in the overweight and obese population in Belgium
Nick Verhaeghe
Lieven Annemans
A1
Journal Article
in
PUBLIC HEALTH
2016
The social cost of legal and illegal drugs in Belgium
Delfine Lievens
Freya Vander Laenen
Nick Verhaeghe
Nele Schils
Lieven Pauwels
Wim Hardyns
Lieven Annemans
Book
2016
Total-body examination vs lesion-directed skin cancer screening
Isabelle Hoorens
Lore Pil
Barbara Boone
Sofie De Schepper
Katia Ongenae
Lieven Annemans
Ines Chevolet
Lieve Brochez
A1
Journal Article
in
JAMA DERMATOLOGY
2016
Using linked administrative and disease-specific databases to study end-of-life care on a population level
Kristof Faes
Dirk Houttekier
Luc Deliens
Lieven Annemans
A1
Journal Article
in
BMC PALLIATIVE CARE
2016
2015
An ongoing multinational observational study in multiple myeloma (preamble): a preliminary report of disease impact on quality of life
Lieven Annemans
C3
Conference
2015
Analysis of in-hospital resource use after an ischemic stroke
Sarah Dewilde
Lieven Annemans
C3
Conference
2015
Analysis of primary and secondary APR-DRG codes of an ischemic stroke admission
Sarah Dewilde
Lieven Annemans
C3
Conference
2015
Clinical and economic value of in-hospital clinical pharmacy activities form a health care perspective
Barbara Claus
Lieven Annemans
Hugo Robays
Dissertation
2015
Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients : findings from the EPICOR study
Lieven Annemans
A2
Journal Article
in
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
2015
Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
Lieven Annemans
A1
Journal Article
in
FRONTIERS IN PHARMACOLOGY
2015
Effectiveness of nurse-led telecoaching in optimising diabetes control: results of a randomised controlled trial in patients with type 2 diabetes
Lieven Annemans
C3
Conference
2015
Effectiveness of supporting informal caregivers of people with dementia: a systematic review
Sophie Vandepitte
Nele Van Den Noortgate
Sofie Verhaeghe
Kristof Faes
Lieven Annemans
C3
Conference
2015
EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring
Lieven Annemans
A1
Journal Article
in
EUROPEAN HEART JOURNAL
2015
Gonadotropin therapy versus laparoscopic ovarian drilling in clomiphene citrate-resistant polycystic ovary syndrome patients: a retrospective cost-effectiveness analysis
Veerle De Frene
Jan Gerris
Steven Weyers
Marc Dhont
Stijn Vansteelandt
Lieven Annemans
Petra De Sutter
A1
Journal Article
in
GYNECOLOGIC AND OBSTETRIC INVESTIGATION
2015
High event rate in patients with acute coronary syndromes and atrial fibrillation: results from the prospective EPICOR Registry
Lieven Annemans
C3
Conference
2015
How to reform western care payment systems according to physicians, policy makers, healthcare executives and researchers: a discrete choice experiment
Lieven Annemans
A1
Journal Article
in
BMC HEALTH SERVICES RESEARCH
2015
Hurdles that impede economic evaluations of health care interventions tested by general practitioners in Flanders: a qualitative study
Jolien Plaete
Ilse De Bourdeaudhuij
Lieven Annemans
C3
Conference
2015
Hurdles that impede economic evaluations of welfare interventions
Janne Schepers
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
2015
Impact of the medical home model on the quality of primary care : the Belgian experience
Lieven Annemans
A1
Journal Article
in
MEDICAL CARE
2015
In the eye of the beholder : a qualitative study of mutual obligations and areas of ambiguity in the Hospital-physician relationship
Jeroen Trybou
Paul Gemmel
Lieven Annemans
A2
Journal Article
in
INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT
2015
Investigating the relationship between 'Severity Of Illness' and the 'Modified Rankin Scale' in ischemic stroke patients with response mapping
Sarah Dewilde
Lieven Annemans
C3
Conference
2015
Long-term quality of life in critically ill patients with acute kidney injury treated with renal replacement therapy : a matched cohort study
Sandra Oeyen
Wouter De Corte
Dominique Benoit
Lieven Annemans
Annemieke Dhondt
Raymond Vanholder
Johan Decruyenaere
Eric Hoste
A1
Journal Article
in
CRITICAL CARE
2015
Methodological considerations in estimating the public expenditures related to health for addictive substances: a literature review
Nick Verhaeghe
Lieven Annemans
Delfine Lievens
Freya Vander Laenen
C1
Conference
2015
Perceptions from mental health nurses about health promotion : a qualitative study
Nick Verhaeghe
Jan De Maeseneer
Lea Maes
Cornelis Van Heeringen
Lieven Annemans
C3
Conference
2015
Predictors of one-year mortality at hospital discharge after acute coronary syndromes : a new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
Lieven Annemans
A2
Journal Article
in
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
2015
Prevalence and management of antibiotic associated diarrhea in general hospitals
Lieven Annemans
A1
Journal Article
in
BMC INFECTIOUS DISEASES
2015
Probabilistic Markov model estimating cost effectiveness of methylphenidate osmotic-release oral system versus immediate-release methylphenidate in children and adolescents: which information is needed?
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2015
Provider accountability as a driving force towards physician-hospital integration : a systematic review
Jeroen Trybou
Paul Gemmel
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF INTEGRATED CARE
2015
Psychological, perinatal, lifestyle and health-economic aspects of the polycystic ovary syndrome : what really matters for the patient, her family and the society
Veerle De Frene
Petra De Sutter
Lieven Annemans
Dissertation
2015
Self-reported health status in coronary heart disease patients: a comparison with the general population
Delphine De Smedt
Els Clays
Lieven Annemans
Sofie Pardaens
Dirk De Bacquer
A1
Journal Article
in
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING
2015
Stroke and systemic embolism prevention in patients with atrial fibrillation in Belgium: comparative cost effectiveness of new oral anticoagulants and warfarin
Lieven Annemans
A1
Journal Article
in
CLINICAL DRUG INVESTIGATION
2015
The cost of pressure ulcer prevention and treatment in hospitals and nursing homes in Flanders: a cost-of-illness study
Liesbet Demarré
Sofie Verhaeghe
Lieven Annemans
Ann Van Hecke
Maria Grypdonck
Dimitri Beeckman
A1
Journal Article
in
INTERNATIONAL JOURNAL OF NURSING STUDIES
2015
The cost of prevention and treatment of pressure ulcers: A systematic review
Liesbet Demarré
Aurélie Van Lancker
Ann Van Hecke
Sofie Verhaeghe
Maria Grypdonck
Lieven Annemans
Dimitri Beeckman
A1
Journal Article
in
INTERNATIONAL JOURNAL OF NURSING STUDIES
2015
The impact of professional and organizational identification on the relationship between hospital-physician exchange and customer-oriented behaviour of physicians
Jeroen Trybou
Katrien Verleye
Paul Gemmel
Lieven Annemans
A1
Journal Article
in
HUMAN RESOURCES FOR HEALTH
2015
Treatment and long-term results of acute coronary syndrome (ACS) in patients on chronic oral anticoagulants (OAC): data from the EPICOR (NCT01171404) study
Lieven Annemans
C3
Conference
2015
Wie betaalt de rekening? De sociale kost van tabak, alcohol, psychoactieve medicatie en illegale middelen
Freya Vander Laenen
Delfine Lievens
Lieven Pauwels
Wim Hardyns
Nele Schils
Lieven Annemans
Nick Verhaeghe
U
Conference
2015
2014
A multinational observational study in multiple myeloma (preamble): assessment of disease impact on work productivity and activity
Lieven Annemans
C3
Conference
2014
A multinational observational study in multiple myeloma (preamble): initial results of treatment patterns
Lieven Annemans
C3
Conference
2014
A review of the methodological challenges in assessing the cost effectiveness of pharmacist interventions
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2014
Applying the Intervention Mapping protocol to develop a kindergarten-based, family-involved intervention to increase European preschool children's physical activity levels: the ToyBox-study
Marieke De Craemer
Ellen De Decker
Ilse De Bourdeaudhuij
Maïté Verloigne
Evangelia Grammatikaki
Greet Cardon
Lieven Annemans
Stefaan De Henauw
Lea Maes
Carine Vereecken
Lore Pil
A1
Journal Article
in
OBESITY REVIEWS
2014
Cost effectiveness of apixaban versus aspirin for stroke prevention in patients with non-valvular atrial fibrillation in Belgium
Lieven Annemans
A1
Journal Article
in
CLINICAL DRUG INVESTIGATION
2014
Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2014
Cost-effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER)
Lieven Annemans
Nick Verhaeghe
A1
Journal Article
in
PHARMACOECONOMICS
2014
Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care
Nick Verhaeghe
Delphine De Smedt
Jan De Maeseneer
Lea Maes
Cornelis Van Heeringen
Lieven Annemans
A1
Journal Article
in
BMC PUBLIC HEALTH
2014
Developing the intervention material to increase physical activity levels of European preschool children: the ToyBox-study
Marieke De Craemer
Ellen De Decker
Ilse De Bourdeaudhuij
Lieven Annemans
Evangelia Grammatikaki
Greet Cardon
Stefaan De Henauw
Lea Maes
Carine Vereecken
Lore Pil
A1
Journal Article
in
OBESITY REVIEWS
2014
EQ-5D versus SF-12 in coronary patients: are they interchangeable?
Delphine De Smedt
Els Clays
Lieven Annemans
Dirk De Bacquer
A1
Journal Article
in
VALUE IN HEALTH
2014
Effects of physician-owned specialized facilities in health care: a systematic review
Jeroen Trybou
Melissa De Regge
Paul Gemmel
Philippe Duyck
Lieven Annemans
A1
Journal Article
in
HEALTH POLICY
2014
Establishing a method to estimate the cost-effectiveness of a kindergarten-based, family-involved intervention to prevent obesity in early childhood: the ToyBox-study
Lore Pil
Greet Cardon
Ilse De Bourdeaudhuij
Lieven Annemans
A1
Journal Article
in
OBESITY REVIEWS
2014
Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups
Barbara Claus
Hugo Robays
Johan Decruyenaere
Lieven Annemans
A1
Journal Article
in
JOURNAL OF EVALUATION IN CLINICAL PRACTICE
2014
Hospital-physician exchanges : the moderating effects of the Chief Medical Officer and organizational trust
Jeroen Trybou
Paul Gemmel
Lieven Annemans
C1
Conference
2014
Hospital-physician relations : the relative importance of economic, relational and professional attributes to organizational attractiveness
Jeroen Trybou
Paul Gemmel
Lieven Annemans
A1
Journal Article
in
BMC HEALTH SERVICES RESEARCH
2014
How to govern physician-hospital exchanges: contractual and relational issues in Belgian hospitals
Jeroen Trybou
Paul Gemmel
Lieven Annemans
A1
Journal Article
in
JOURNAL OF HEALTH SERVICES RESEARCH & POLICY
2014
Long-term outcome and quality of life in ICU patients with acute kidney injury treated with renal replacement therapy: a case control study
Wouter De Corte
Sandra Oeyen
Lieven Annemans
Dominique Benoit
Annemieke Dhondt
Raymond Vanholder
Johan Decruyenaere
Eric Hoste
C3
Conference
2014
Nurse-led telecoaching of people with type 2 diabetes in primary care: rationale, design and baseline data of a randomized controlled trial
Lieven Annemans
A1
Journal Article
in
BMC FAMILY PRACTICE
2014
Physician-hospital alignment : economic, administrative and professional aspects
Jeroen Trybou
Paul Gemmel
Lieven Annemans
Dissertation
2014
Physician-hospital exchanges: the moderating effects of the Chief Medical Officer
Jeroen Trybou
Lieven Annemans
Paul Gemmel
C3
Conference
2014
Place of residence and employment status after stroke
Sarah Dewilde
Lieven Annemans
C3
Conference
2014
Pre- and in-hospital healthcare resource use in survivors of acute coronary syndromes in the EPICOR registry
Lieven Annemans
C3
Conference
2014
Predictors of 1-year mortality at hospital discharge after acute coronary syndromes: a new risk score from the EPICOR study
Lieven Annemans
C3
Conference
2014
Pressure ulcers : predicting factors, prevention and costs
Liesbet Demarré
Dimitri Beeckman
Lieven Annemans
Dissertation
2014
Quality of life decrements after stroke
Sarah Dewilde
Lieven Annemans
C3
Conference
2014
Risk factor awareness in a coronary population and the association with health-related quality of life outcomes
Delphine De Smedt
Els Clays
Lieven Annemans
Dirk De Bacquer
C3
Conference
2014
Risk factor awareness in a coronary population and the association with health-related quality of life outcomes
Delphine De Smedt
Els Clays
Lieven Annemans
Sofie Pardaens
Dirk De Bacquer
A1
Journal Article
in
INTERNATIONAL JOURNAL OF PUBLIC HEALTH
2014
Self-operated endovaginal telemonitoring versus traditional monitoring of ovarian stimulation in assisted reproduction: an RCT
Jan Gerris
Frank Vandekerckhove
Ellen Deschepper
Dirk De Bacquer
Lore Pil
Lieven Annemans
Petra De Sutter
A1
Journal Article
in
HUMAN REPRODUCTION
2014
The association between self-reported lifestyle changes and health-related quality of life in coronary patients: the EUROASPIRE III survey
Delphine De Smedt
Els Clays
Lieven Annemans
Hedwig Boudrez
Johan De Sutter
Sofie Pardaens
Dirk De Bacquer
A1
Journal Article
in
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
2014
2013
A multidisciplinary and multi-method research framework for studying integrated care in Flanders (Belgium)
Lieven Annemans
C3
Conference
2013
A new multinational observational study in multiple myeloma: initial report of the PREAMBLE study
Lieven Annemans
C3
Conference
2013
Attitudes toward supplementary criteria in the reimbursement process in Poland
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
2013
Belgian cost-effectiveness analysis of hydroxocobalamin (Cyanokit) in known or suspected cyanide poisoning
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE
2013
Comparing the health-related quality of life status between coronary patients and the general population in 11 European countries
Delphine De Smedt
Els Clays
Lieven Annemans
Dirk De Bacquer
C3
Conference
2013
Cost-effectiveness of a helpline for suicide prevention
Lore Pil
Gwendolyn Portzky
Lieven Annemans
A1
Journal Article
in
JOURNAL OF TELEMEDICINE AND TELECARE
2013
Costs associated with readmissions in Belgian acute-care hospitals
Jeroen Trybou
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2013
Current methodological issues in the economic assessment of personalized medicine
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2013
De kosteneffectiviteit van bevolkingsonderzoek naar baarmoederhals-, borst- en dikkedarmkanker: een systematische review van de internationale literatuur
Lore Pil
Lieven Annemans
Report
2013
Determining economic impact of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices (PINCER)
Nick Verhaeghe
Lieven Annemans
C3
Conference
2013
Differential pricing of new pharmaceuticals in lower income European countries
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
2013
Direct medical costs of COPD diagnosis and treatment, Eastern vs. Western European country : examples of Serbia and Belgium
Nick Verhaeghe
Lieven Annemans
A2
Journal Article
in
FARMECONOMIA, HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS
2013
EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics
Lieven Annemans
A1
Journal Article
in
AMERICAN HEART JOURNAL
2013
Effectiveness and cost-effectiveness of a health promotion intervention targeting physical activity and healthy eating in individuals with mental disorders
Nick Verhaeghe
Lieven Annemans
Lea Maes
Dissertation
2013
Evidence-based health care policy in reimbursement decisions : lessons from a series of six equivocal case-studies
Lieven Annemans
A1
Journal Article
in
PLOS ONE
2013
Feasibility study of a Hadron Therapy Centre in Belgium
Lieven Annemans
Francis Colardyn
Wilfried De Neve
Fréderic Duprez
Yolande Lievens
Indira Madani
Piet Ost
Katrien Vandecasteele
Barbara Vanderstraeten
Liv Veldeman
Nick Verhaeghe
Report
2013
Health economic (HE) data requirements and availability in the European Union: results of a survey
Lieven Annemans
C3
Conference
2013
Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial
Nick Verhaeghe
Els Clays
Carine Vereecken
Jan De Maeseneer
Lea Maes
Cornelis Van Heeringen
Dirk De Bacquer
Lieven Annemans
A1
Journal Article
in
BMC PUBLIC HEALTH
2013
Health promotion in mental health care: perceptions from patients and mental health nurses
Nick Verhaeghe
Jan De Maeseneer
Lea Maes
Cornelis Van Heeringen
Lieven Annemans
A1
Journal Article
in
JOURNAL OF CLINICAL NURSING
2013
Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey
Delphine De Smedt
Els Clays
Lieven Annemans
Dirk De Bacquer
A1
Journal Article
in
INTERNATIONAL JOURNAL OF CARDIOLOGY
2013
Healthcare payment reforms across western countries on three continents: lessons from stakeholder preferences when asked to rate the supportiveness for fulfilling patients' needs
Lieven Annemans
A1
Journal Article
in
HEALTH POLICY
2013
Hospital-acquired infections in Belgian acute-care hospitals: burden of disease and potential cost savings
Jeroen Trybou
Lieven Annemans
C3
Conference
2013
Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings
Jeroen Trybou
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2013
Hospital-physician relationships: a mixed-method study of hospital-physician exchanges in Belgian hospitals
Jeroen Trybou
Paul Gemmel
Lieven Annemans
C3
Conference
2013
Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study
Sandra Oeyen
Dominique Benoit
Lieven Annemans
Pieter Depuydt
Simon Van Belle
Roberto Troisi
Lucien Noens
Piet Pattyn
Johan Decruyenaere
A1
Journal Article
in
INTENSIVE CARE MEDICINE
2013
Longitudinal economic consequences of colorectal cancer in a university hospital setting
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2013
Medical homes versus individual practice in primary care impact on health care expenditures
Lieven Annemans
A1
Journal Article
in
MEDICAL CARE
2013
Medically managed patients with non ST-segment elevation acute coronary syndromes: frequency, subgroups and outcomes: insights from the Multinational EPICOR study
Lieven Annemans
C3
Conference
2013
Physician-owned specialized facilities: focused factories or destructive competition?: a systematic review.
Melissa De Regge
Jeroen Trybou
Paul Gemmel
Philippe Duyck
Lieven Annemans
C1
Conference
2013
Predictors of 1-year mortality at hospital discharge after ACS STEMI and NSTE-ACS: a new risk score from the EPICOR study
Lieven Annemans
C3
Conference
2013
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
Lieven Annemans
A1
Journal Article
in
BMC CANCER
2013
Proton radiotherapy for locally-advanced non-small cell lung cancer, a cost-effective alternative to photon radiotherapy in Belgium?
Yolande Lievens
Nick Verhaeghe
Wilfried De Neve
Indira Madani
Barbara Vanderstraeten
Lieven Annemans
C3
Conference
2013
Readmissions in Belgian acute-care hospitals : burden of disease and potential cost savings
Jeroen Trybou
Lieven Annemans
C3
Conference
2013
Reflections on market access for personalized medicine: recommendations for Europe
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2013
Self-operated endo-vaginal tele-monitoring (SOET) as an alternative for traditional monitoring of the stimulation phase of IVF/ICSI cycles: preliminary results of a randomized comparison
Jan Gerris
Frank Vandekerckhove
Ewout Vansteenkiste
Ellen Deschepper
Lore Pil
Dirk De Bacquer
Lieven Annemans
Petra De Sutter
C3
Conference
2013
Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study)
Lieven Annemans
A1
Journal Article
in
TRIALS
2013
Stratified medicine: a call for action
Lieven Annemans
Editorial material
2013
Systematic review on the cost-effectiveness of therapeutic education to prevent the development and progression of type 2 diabetes
Lore Pil
Lieven Annemans
C3
Conference
2013
Technologische hulpmiddelen binnen de zorg: overheidstussenkomst en de invloed op ondernemerschap
Lore Pil
Lieven Annemans
Report
2013
Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
2013
2012
A cost-effectiveness analysis of pressure ulcer prevention in Belgian hospitals, phase 1 : direct time observations and a Delphi procedure to develop stand nursing times for activities related to pressure ulcer prevention
Dimitri Beeckman
Sofie Verhaeghe
Ann Van Hecke
Lieven Annemans
Liesbet Demarré
C3
Conference
2012
A cost-effectiveness study of the community-based intervention '10 000 Steps Ghent'
Delphine De Smedt
Katrien De Cocker
Lieven Annemans
Ilse De Bourdeaudhuij
Greet Cardon
A1
Journal Article
in
PUBLIC HEALTH NUTRITION
2012
A critical literature review of health economic evaluations in pertussis booster vaccination
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
2012
A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
2012
A systematic approach for the development of a kindergarten-based intervention for the prevention of obesity in preschool age children: the ToyBox-study
Lieven Annemans
Ilse De Bourdeaudhuij
A1
Journal Article
in
OBESITY REVIEWS
2012
An assessement of the cost-effectiveness of escitalopram versus multiple comparators as first line antidepressant in patients with major depressive disorder (MDD) in Belgium
Lieven Annemans
C3
Conference
2012
An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
2012
Availability of cath lab facilities and contemporary inter-hospital transfer patterns for the management of ACS patients: findings from the EPICOR study
Lieven Annemans
C3
Conference
2012
Can we still afford expensive cancer drugs?
Lieven Annemans
Simon Van Belle
Editorial material
2012
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR Personalized Medicine Special Interest Group
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2012
Changes to the statin prescribing policy in Belgium potential impact in clinical and economic terms
Lieven Annemans
A1
Journal Article
in
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
2012
Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU
Lieven Annemans
A1
Journal Article
in
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH
2012
Contemporary pre-hospital management of ACS patients: results from the EPICOR study
Lieven Annemans
C3
Conference
2012
Cost effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
2012
Cost-effectiveness analysis of a helpline for suicide prevention
Lore Pil
Lieven Annemans
Gwendolyn Portzky
C3
Conference
2012
Cost-effectiveness in health care programs: a literature review
Omer Vanhaute
Lieven Annemans
C3
Conference
2012
Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project
Delphine De Smedt
Dirk De Bacquer
Gui De Backer
Lieven Annemans
A1
Journal Article
in
EUROPEAN HEART JOURNAL
2012
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment : evidence from the RESTORE trial
Lieven Annemans
A1
Journal Article
in
BRITISH JOURNAL OF OPHTHALMOLOGY
2012
Current regional differences in the use of antiplatelet drugs for the treatment of acute coronary syndromes: results from the EPICOR study
Lieven Annemans
C3
Conference
2012
Economic evaluation of different treatment modalities in acute kidney injury
Delphine De Smedt
Monique Elseviers
Lieven Annemans
A1
Journal Article
in
NEPHROLOGY DIALYSIS TRANSPLANTATION
2012
Economic evaluation of vaccines: considerations on evidence, discounting, models and futures challenges
Lieven Annemans
C3
Conference
2012
Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial
Lieven Annemans
A1
Journal Article
in
JOURNAL OF HOSPITAL MEDICINE
2012
Health promotion intervention in mental health care : design and baseline findings of a cluster preference randomized controlled trial
Nick Verhaeghe
Jan De Maeseneer
Lea Maes
Cornelis Van Heeringen
Veerle Bogaert
Els Clays
Dirk De Bacquer
Lieven Annemans
A1
Journal Article
in
BMC PUBLIC HEALTH
2012
How can we measure the impact of clinical pharmacy interventions?: a retrospective drug cost analysis
Hugo Robays
Lieven Annemans
C3
Conference
2012
In the eye of the beholder: mutual obligations and areas of ambiguity in the hospital-physician relationship
Jeroen Trybou
Lieven Annemans
Paul Gemmel
C1
Conference
2012
Inventory of European databases related to cardiovascular diseases
Delphine De Smedt
Lieven Annemans
Editorial material
2012
Kosteneffectiviteit van chronische zuurstoftherapie bij COPD-patiënten met ernstige hypoxemie
Lieven Annemans
Eric Derom
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2012
Market uptake of orphan drugs: a European analysis
Lieven Annemans
A1
Journal Article
in
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
2012
Maximizing health through the rapidly developing fields of comparative and cost-effectiveness
Lieven Annemans
Editorial material
2012
Quality of life and its association with prevalences and therapeutic control of cardiovascular risk factors in CHD patients
Delphine De Smedt
Lieven Annemans
Dirk De Bacquer
C3
Conference
2012
The (very) old patient admitted to the ICU: evaluation of long-term outcomes, quality of life, costs, and cost-effectiveness
Sandra Oeyen
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
C3
Conference
2012
The impact of treatment with risperidone long-acting injection on the Belgian healthcare system: results from a budget impact model
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2012
The patient with decompensated liver cirrhosis admitted to the ICU: evaluation of outcomes, quality of life, costs, and cost-effectiveness
Sandra Oeyen
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
C3
Conference
2012
The patient with hematological malignancy admitted to the ICU: evaluation of outcomes, quality of life, costs, and cost-effectiveness
Sandra Oeyen
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
C3
Conference
2012
Vaccination against Herpes zoster and post-herpetic neuralgia in France: a cost-effectiveness analysis
Lieven Annemans
C3
Conference
2012
2011
A cost-effectiveness analysis of vaccinating the elderly with 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany
Lieven Annemans
C3
Conference
2011
A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results
Jo Lambert
Jessica Bostoen
Barbara Geusens
Jan Bourgois
Jan Boone
Delphine De Smedt
Lieven Annemans
A1
Journal Article
in
ARCHIVES OF DERMATOLOGICAL RESEARCH
2011
Clinical and economic impact of antithrombotic management patterns in acute coronary syndromes: rationale and design of the EPICOR study
Lieven Annemans
C3
Conference
2011
Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAS) in cancer patients receiving chemotherapy: a multicountry approach
Lieven Annemans
C3
Conference
2011
Cost analysis of anemia treatment with erythropoiesis-stimulating agents (ESAS) in cancer patients receiving chemotherapy in Italy
Lieven Annemans
C3
Conference
2011
Cost analysis: treatment of chemotherapy-induced anaemia with erythropoiesis-stimulating agents (ESAS) in Spain
Lieven Annemans
C3
Conference
2011
Cost effectiveness of treatments for wet age-related macular degeneration
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2011
Cost-utility analysis of ranibizumab (lucentis®) in wet-AMD based on real-life data collected in the HELIOS study after ranibizumab reimbursement in Belgium
Lieven Annemans
C3
Conference
2011
De financiering pediatrie: een kritische reflectie en aanbevelingen tot het verbeteren van de financiering van kortverblijvende kinderen voor arts en ziekenhuis
Jeroen Trybou
Lieven Annemans
Bookchapter
in
Organisation et financement des activités pédiatriques de courts séjours : rapport final
2011
Deriving reference values and utilities for the QoL-AGHDA in adult GHD
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF HEALTH ECONOMICS
2011
Economic impact of enoxaparin after acute ischemic stroke based on PREVAIL
Lieven Annemans
A1
Journal Article
in
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
2011
Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review
Nick Verhaeghe
Jan De Maeseneer
Lea Maes
Cornelis Van Heeringen
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
2011
Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial
Els Mehuys
Lucas Van Bortel
Leen De Bolle
Inge Van Tongelen
Lieven Annemans
Jean Paul Remon
A1
Journal Article
in
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
2011
Extrapolation in oncology modelling: novel methods for novel compounds
Lieven Annemans
C3
Conference
2011
Health technology assessments in personalized medicine : illustrations for cost-effectiveness analysis
Dominique Vandijck
Lieven Annemans
Editorial material
2011
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices, part 1
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2011
Methodological challenges for economic evaluations of vaccination programs: the case of pertussis booster vaccination
Lieven Annemans
C3
Conference
2011
Modelling budget impact (BI) of vaccinating at-risk adults and the elderly with 23-valent pneumococcal polysaccharide vaccine (PPV23) compared to 13-valent pneumococcal conjugate vaccine (PCV13) in Germany
Lieven Annemans
C3
Conference
2011
Organisatie van geestelijke gezondheidszorg voor kinderen en jongeren : literatuurstudie en internationaal overzicht
Gijs Mommerency
Nick Verhaeghe
Lieven Annemans
Report
2011
Organisation et financement des activités pédiatriques de courts séjours: rapport final
Lieven Annemans
Nick Verhaeghe
Jeroen Trybou
Report
2011
Pay-for-performance step-by-step: introduction to the MIMIQ model
Lieven Annemans
Delphine De Smedt
A1
Journal Article
in
HEALTH POLICY
2011
Perceptions of mental health nurses and patients about health promotion in mental health care: a literature review
Nick Verhaeghe
Jan De Maeseneer
Lea Maes
Cornelis Van Heeringen
Lieven Annemans
A1
Journal Article
in
JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING
2011
Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain
Lieven Annemans
A1
Journal Article
in
CLINICAL DRUG INVESTIGATION
2011
Stimulating pharmaceutical innovation in the EU
Lieven Annemans
Editorial material
2011
The equity dimension in evaluations of the quality and outcomes framework: a systematic review
Pauline Boeckxstaens
Delphine De Smedt
Jan De Maeseneer
Lieven Annemans
Sara Willems
A1
Journal Article
in
BMC HEALTH SERVICES RESEARCH
2011
The euros and sense of stents: do we get value for money?
Lieven Annemans
A1
Journal Article
in
JOURNAL OF CARDIOVASCULAR MEDICINE
2011
The ties that bind: an integrative framework of physician-hospital alignment
Jeroen Trybou
Paul Gemmel
Lieven Annemans
A1
Journal Article
in
BMC HEALTH SERVICES RESEARCH
2011
Valuation of HR-QOL utilities by the EQ-5D in a group of chronically ill patients
Renaat Peleman
Lieven Annemans
C3
Conference
2011
2010
An integrative model of the management of hospital physician relationships
Jeroen Trybou
Paul Gemmel
Lieven Annemans
C1
Conference
2010
Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative Atorvastatin diabetes study in the Belgian population
Lieven Annemans
A1
Journal Article
in
CLINICAL DRUG INVESTIGATION
2010
Cost-effectiveness of 2 diabetes health care programmes in Belgium
Karolien Benoit
Lieven Annemans
C3
Conference
2010
Cost-effectiveness of a European community-based intervention : '10.000 steps Ghent'
Delphine De Smedt
Katrien De Cocker
Greet Cardon
Ilse De Bourdeaudhuij
Lieven Annemans
C3
Conference
2010
Cost-effectiveness of catch-up programs in human papillomavirus vaccination
Lieven Annemans
A1
Journal Article
in
EXPERT REVIEW OF VACCINES
2010
Economic evaluation of different treatment modalities in acute kidney injury
Delphine De Smedt
Lieven Annemans
C3
Conference
2010
Estimating the length of hospitalization attributable to multidrug antibiotic resistance
Stijn Blot
Dominique Vandijck
Lieven Annemans
Dirk Vogelaers
A1
Journal Article
in
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
2010
Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines
Marc Twagirumukiza
Lieven Annemans
Jan Kips
Lucas Van Bortel
A1
Journal Article
in
TROPICAL MEDICINE & INTERNATIONAL HEALTH
2010
Progress in vaccines, progress in health economics
Lieven Annemans
Editorial material
2010
Projected reduction in healthcare costs in Belgium after optimization of iodine intake : impact on costs related to thyroid nodular disease
Lieven Annemans
Herman Van Oyen
A1
Journal Article
in
THYROID
2010
Quality of life after intensive care: a systematic review of the literature
Sandra Oeyen
Dominique Vandijck
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
A1
Journal Article
in
CRITICAL CARE MEDICINE
2010
Quality of life before, 3 months and 1 year after ICU discharge
Sandra Oeyen
Dominique Benoit
Lieven Annemans
Johan Decruyenaere
C3
Conference
2010
Risk-sharing schemes worldwide: a landscape analysis of health outcomes-based reimbursement agreements
Lieven Annemans
C3
Conference
2010
Systematic review: effects, design choices, and context of pay-for-performance in health care
Delphine De Smedt
Lieven Annemans
A1
Journal Article
in
BMC HEALTH SERVICES RESEARCH
2010
The use of health promotion initiatives by municipalities in Belgium: a retrospective observational study
Nick Verhaeghe
Lieven Annemans
C3
Conference
2010
2009
A health economic evaluation of a new Herpes zoster (HZ) vaccine for the prevention of HZ and post-herpetic neuralgia (PHN) in Belgium
Lieven Annemans
C3
Conference
2009
AGREEMENT BETWEEN PATIENT AND PROXY ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE BEFORE INTENSIVE CARE UNIT ADMISSION
Dominique Vandijck
Sandra Oeyen
Lieven Annemans
Johan Decruyenaere
C3
Conference
2009
Applying the efficiency frontier in pharmaceutical policy making. A case study in treatment resistant HIV/AIDS patients in the German setting
Lieven Annemans
C3
Conference
2009
Comment on "Health-related quality of life as a prognostic factor of survival in critically ill patients"
Dominique Vandijck
Sandra Oeyen
Lieven Annemans
Johan Decruyenaere
A1
Journal Article
in
INTENSIVE CARE MEDICINE
2009
Cost effectiveness of Varenicline in Belgium, compared with Bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation : a BENESCO Markov cost-effectiveness analysis
Lieven Annemans
A1
Journal Article
in
CLINICAL DRUG INVESTIGATION
2009
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium
Lieven Annemans
A1
Journal Article
in
Pharmacoeconomics
2009
Cost-effectiveness of health promoting interventions
Delphine De Smedt
Madeleine Bakker
Lieven Annemans
C3
Conference
2009
Effectiveness and cost-effectiveness of lifestyle interventions in persons with severe mental disorders: a systematic review
Nick Verhaeghe
Jan De Maeseneer
Lea Maes
Cornelis Van Heeringen
Lieven Annemans
C3
Conference
2009
Fentanyl HCI iontophoretic transdermal system versus morphine IV-PCA for postoperative pain management: survey of healthcare provider opinion
Lieven Annemans
A1
Journal Article
in
Current Medical Research and Opinion
2009
Hospital costs in patients with nosocomial Methicillin-resistant or Methicillin-susceptible Staphylococcus aureus bloodstream infection
Dominique Vandijck
Lieven Annemans
Dirk Vogelaers
Stijn Blot
A1
Journal Article
in
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
2009
Intensifying dialysis: how far should we go and at what cost?
Lieven Annemans
A1
Journal Article
in
Nephrology Dialysis Transplantation
2009
Kosteneffectiviteit van acties ter bevordering van gezonde voeding en lichaamsbeweging -een "rapid assessment" voor de beleidsmaker
Delphine De Smedt
Madeleine Bakker
Lieven Annemans
A2
Journal Article
in
Vereniging voor Gezondheidseconomie Bulletin
2009
Outcome and resources use of severe burn injury patients with nosocomial bloodstream infection : results of a matched cohort study
Nele Brusselaers
Stan Monstrey
Eric Hoste
Dominique Vandijck
Linos Vandekerckhove
Lieven Annemans
Dirk Vogelaers
Stijn Blot
C3
Conference
2009
PREDICTING COST-EFFECTIVENESS OF A DIABETES HEALTH CARE PROGRAM IN BELGIUM AS A POLICY MANAGEMENT TOOL
Karolien Benoit
Patricia Sunaert
Lieven Annemans
C3
Conference
2009
Patients admitted to the ICU after cardiopulmonary resuscitation: an analysis of outcome, quality of life and cost-effectiveness
Sandra Oeyen
Dominique Vandijck
Dominique Benoit
Lieven Annemans
Francis Colardyn
Johan Decruyenaere
C3
Conference
2009
Proteinuria and clinical outcomes in hypertensive patients
Lieven Annemans
A1
Journal Article
in
AMERICAN JOURNAL OF HYPERTENSION
2009
Psychological well-being and socio-economic hardship among AIDS orphans and other vulnerable children in Guinea
Wim Delva
Stijn Vansteelandt
Petra De Koker
Marleen Temmerman
Lieven Annemans
A1
Journal Article
in
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
2009
Societal and patient burden of fibromyalgia syndrome
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2009
Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authorities
Veronique Cocquyt
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2009
Voordelen, nadelen en haalbaarheid van het invoeren van ‘Pay for Quality’ programma’s in België
Lieven Annemans
Pauline Boeckxstaens
Delphine De Smedt
Sara Willems
Report
2009
2008
A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2008
A model to evaluate the cost-effectiveness of ranibizumab
Lieven Annemans
A1
Journal Article
in
EJHP Practice
2008
An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2008
Belgian budget impact analyses of aliskiren (Tekturna/Rasilez) in hypertension
Lieven Annemans
C3
Conference
2008
Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination
Lieven Annemans
A1
Journal Article
in
Vaccine
2008
Cost-effeciveness of Fentanyl its (ionsys(TM)) in post-operative pain management: a finnish hospital perspective analysis
Lieven Annemans
C3
Conference
2008
Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in Belgium
Lieven Annemans
A1
Journal Article
in
SUPPORTIVE CARE IN CANCER
2008
Cost-effectiveness of I-123-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy
Lieven Annemans
A1
Journal Article
in
Movement Disorders
2008
Cost-effectiveness of aliskiren as add on to losartan and optimal an tihypertensive therapy in patients with type 2 diabetes, hypertension and nephropathy in the UK setting
Lieven Annemans
C3
Conference
2008
Cost-effectiveness of darbepoetin a in an every-3-weeks schedule
Lieven Annemans
A1
Journal Article
in
BULLETIN DU CANCER
2008
Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection
Dominique Vandijck
Sonia Labeau
Pieter Depuydt
Lieven Annemans
Franky Buyle
Sandra Oeyen
Kirsten Colpaert
Renaat Peleman
Stijn Blot
Johan Decruyenaere
A1
Journal Article
in
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
2008
Effectiveness of pharmacist intervention for asthma control improvement
Els Mehuys
Lucas Van Bortel
Leen De Bolle
Inge Van Tongelen
Lieven Annemans
Jean Paul Remon
Guy Brusselle
A1
Journal Article
in
EUROPEAN RESPIRATORY JOURNAL
2008
First results of effectiveness of 12 week training program ('OnderHUIDs') for patients with selected dermatoses
Lieven Annemans
C3
Conference
2008
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005
Lieven Annemans
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2008
Health economic consequences related to the diagnosis of Fibromyalgia syndrome
Lieven Annemans
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2008
Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients
Lieven Annemans
A1
Journal Article
in
International Journal of Colorectal Disease
2008
Health economic evaluation of treating anemia in cancer patients receiving chemotherapy: A study in Belgian hospitals
Simon Van Belle
Lieven Annemans
A1
Journal Article
in
ONCOLOGIST
2008
Injury rate and socioeconomic costs resulting from sports injuries in Flanders: data derived from sports insurance statistics 2003
Lieven Annemans
A1
Journal Article
in
BRITISH JOURNAL OF SPORTS MEDICINE
2008
Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate - A study of cost effectiveness in the Netherlands
Lieven Annemans
A1
Journal Article
in
CNS DRUGS
2008
Medication use and disease management of type 2 diabetes patients in Belgium
Els Mehuys
Leen De Bolle
Lucas Van Bortel
Lieven Annemans
Inge Van Tongelen
Jean Paul Remon
A1
Journal Article
in
PHARMACY WORLD & SCIENCE
2008
Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer - A need for improved modelling to aid decision making
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2008
Pharmaceutical care for type 2 diabetic patients: a randomised controlled trial
Els Mehuys
Leen De Bolle
Lucas Van Bortel
Lieven Annemans
Inge Van Tongelen
Jean Paul Remon
C3
Conference
2008
Priority setting for new technologies: Possible determinants among the working population
Hanne Derycke
Lieven Annemans
C3
Conference
2008
Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma
Lieven Annemans
Christophe Leys
A1
Journal Article
in
EUROPEAN JOURNAL OF DERMATOLOGY
2008
Results of effectiveness of a 12-week educational programme for patients with selected dermatoses
Lieven Annemans
C3
Conference
2008
The Belgian reimbursement procedure (BRP): are added therapeutic value (ATV) and Icer affecting th drug reimbursement decision (DRD)?
Lieven Annemans
C3
Conference
2008
The cost effectiveness of I-123-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2008
The cost-effectiveness of aliskiren as add on to losartan and optimal antihypertensive therapy in patients with type 2 diabetes, hypertension and nephropathy in the United Kingdom setting
Lieven Annemans
C3
Conference
2008
The cost-utility of aliskiren in the treatment of mild to moderate hypertension. A Canadian health care system perspective
Lieven Annemans
C3
Conference
2008
Versterking van de eerstelijn als bijdrage tot een meer rechtvaardige gezondheidszorg
Jan De Maeseneer
Sara Willems
Lieven Annemans
Bookchapter
in
Een rechtvaardige gezondheidszorg
2008
Voriconazole treatment of invasive aspergillosis - Real-world versus health-economic model results
Lieven Annemans
A1
Journal Article
in
CLINICAL DRUG INVESTIGATION
2008
2007
A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (QW_EB) in patients with chemotherapy-induced anemia (CIA): The German case
Lieven Annemans
C3
Conference
2007
A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan
Lieven Annemans
A1
Journal Article
in
INTERNAL MEDICINE
2007
A health economic evaluation of concomitant surgical ablation for atrial fibrillation
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
2007
A health economic model to assess the cost-effectiveness of PEG IFN alpha-2a and ribavirin in patients with mild chronic hepatitis C
Lieven Annemans
A1
Journal Article
in
JOURNAL OF VIRAL HEPATITIS
2007
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels
Lieven Annemans
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2007
Acute kidney injury, length of stay, and costs in patients hospitalized in the intensive care unit
Dominique Vandijck
Sandra Oeyen
Johan Decruyenaere
Lieven Annemans
Eric Hoste
A1
Journal Article
in
ACTA CLINICA BELGICA
2007
Adjuvant trastuzumab treatment in early stage breast cancer: Cost-effectiveness in the Belgian health care setting
Veronique Cocquyt
Lieven Annemans
C3
Conference
2007
Candidemia in the Critical Ill: An economic analysis of daily antimicrobial therapy-related costs
Dominique Vandijck
Stijn Blot
Sandra Oeyen
Kirsten Colpaert
Lieven Annemans
Koenraad Vandewoude
Renaat Peleman
Franky Buyle
Sonia Labeau
Johan Decruyenaere
C3
Conference
2007
Cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (QW_EB) in patients with chemotherapy-induced anemia (CIA): The Italian case
Lieven Annemans
C3
Conference
2007
Cost-effectiveness analysis of the implementation of a quadrivalent (6,11,16,18 types) human papillomavirus vaccine to the existing Belgian cervical cancer screening programme
Lieven Annemans
C3
Conference
2007
Cost-effectiveness in critical care
Dominique Vandijck
Lieven Annemans
Sandra Oeyen
Stijn Blot
Johan Decruyenaere
A4
Journal Article
in
ICU MANAGEMENT
2007
Cost-effectiveness of cetuximab in combination with irinotecan compared with current care in metastatic colorectal cancer after failure on irinotecan - A Belgian analysis
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2007
Cost-effectiveness of darunavir/r in highly treatment-experienced HIV/AIDS patients in different European health care settings
Lieven Annemans
C3
Conference
2007
Critical appraisal of scientific posters comparing anemia treatments for cancer patients: Applying ispor task force guidelines on methodological quality of retrospective studies
Lieven Annemans
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2007
Daily cost of antimicrobial therapy-related costs
Dominique Vandijck
Stijn Blot
Sandra Oeyen
Kirsten Colpaert
Lieven Annemans
Koenraad Vandewoude
Renaat Peleman
Franky Buyle
Sonia Labeau
Johan Decruyenaere
C3
Conference
2007
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation
Lieven Annemans
A1
Journal Article
in
Transplantation proceedings
2007
Een economische analyse van de dagelijkse kostprijs van antimicrobiële therapie bij kritisch zieke patiënten
Dominique Vandijck
Lieven Annemans
Johan Decruyenaere
Renaat Peleman
Franky Buyle
Koenraad Vandewoude
Sonia Labeau
Stijn Blot
C3
Conference
2007
Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
2007
Health economic consequences related to the diagnosis of the fibromyalgia syndrom
Lieven Annemans
C3
Conference
2007
Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases
Lieven Annemans
A1
Journal Article
in
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
2007
Impact of vagus nerve stimulation therapy on cost of care in chronic or recurrent depressive patients resistant to treatment
Lieven Annemans
Kurt Audenaert
C3
Conference
2007
Long-term outcome after acute kidney injury in critically-ill patients
Sandra Oeyen
Dominique Vandijck
Dominique Benoit
Johan Decruyenaere
Lieven Annemans
Eric Hoste
A1
Journal Article
in
ACTA CLINICA BELGICA
2007
Outcomes and costs of hospital-acquired pneumonia associated with pseudomonas or methicillin-resistant Staphylococcus Aureus in a sample of Belgian hospitals
Lieven Annemans
C3
Conference
2007
Principles of good practice for budget impact analysis: Report of the ISPOR task force on good research practices - budget impact analysis
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2007
The relative cost-effectiveness of the fentanyl HCL patient-activated transdermal system (ITS) in acute post-operative pain management (POPM) in Greece
Lieven Annemans
C3
Conference
2007
Treatment patterns and outcomes among patients with skin and softtissue infections in Belgium
Lieven Annemans
C3
Conference
2007
2006
A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension
Lieven Annemans
A1
Journal Article
in
CURRENT MEDICAL RESEARCH AND OPINION
2006
A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (QW_EB) in patients with chemotherapy-induced anemia (CIA): A retrospective study
Lieven Annemans
C3
Conference
2006
A cost-effectiveness analysis of cardiac rehabilitation after percutaneous coronary interventions
Lieven Annemans
C3
Conference
2006
A cost-effectiveness analysis of olmesartan in the treatment of arterial hypertension
Lieven Annemans
C3
Conference
2006
A health economic evaluation of concomitant surgical ablation for atrial fibrillation
Lieven Annemans
C3
Conference
2006
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2006
A multi-country health economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2006
An observational health-economic analysis of the treatment of patients with voriconazole in a real life setting
Lieven Annemans
C3
Conference
2006
Assessment of the economic value of the INTERCEPT blood system in Belgium
Lieven Annemans
A1
Journal Article
in
TRANSFUSION MEDICINE
2006
Burden of illness of abdominal obesity: A retrospective chart review
Lieven Annemans
C3
Conference
2006
Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving either cisplatin-based chemotherapy regimens or moderately emetogenic chemotherapy
Lieven Annemans
C3
Conference
2006
Cost-effectiveness of long acting methylphenidate-OROS in ADHD youths with suboptimal symptom control on immediate-release methylphenidate in The Netherlands
Lieven Annemans
C3
Conference
2006
Costs and outcomes of nosocomial pneumonia in a sample of Belgian hospitals
Lieven Annemans
C3
Conference
2006
Economic evaluation of everolimus and mycophenolate mofetil (MMF) vs azathioprine (AZA) in the novo heart transplantation
Lieven Annemans
C1
Conference
2006
Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma
Lieven Annemans
A1
Journal Article
in
BRITISH JOURNAL OF DERMATOLOGY
2006
Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients
Lieven Annemans
A1
Journal Article
in
EXPERT OPINION ON PHARMACOTHERAPY
2006
Estimating the cost-effectiveness of quality-improving interventions in oral anticoagulation management within general practice
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2006
European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment
Lieven Annemans
A1
Journal Article
in
CANCER TREATMENT REVIEWS
2006
Gezondheidseconomische evaluatie van gecontroleerde lichaamsbeweging
Lieven Annemans
Bookchapter
in
Sportbeleid in Vlaanderen: een verzameling van trends, visies, cijfers, cases, kengetallen en studies
2006
Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease
Lieven Annemans
A1
Journal Article
in
REVISTA ESPANOLA DE CARDIOLOGIA
2006
Hoe kan screening van personen met een familiale anamnese van prematuur coronair lijden worden verbeterd?
Dirk De Bacquer
Stefaan De Henauw
Lea Maes
Lieven Annemans
Gui De Backer
A2
Journal Article
in
Tijdschrift voor Geneeskunde
2006
How to improve screening in first-degree relatives of patients with premature coronary heart disease
Dirk De Bacquer
Stefaan De Henauw
Lea Maes
Lieven Annemans
Gui De Backer
A1
Journal Article
in
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
2006
Long term clinical effect of an HPV-vaccine for the prevention of cervical cancer in France in relation to age of vaccination: Results from a Markov model
Lieven Annemans
C3
Conference
2006
Medical management and costs associated with staphylococcus aureus (SA) bacteraemia in haemodialysis patients: A cost-of-illness study
Lieven Annemans
C3
Conference
2006
Medication use and disease control of asthmatic patients in Flanders: A cross-sectional community pharmacy study
Els Mehuys
Lucas Van Bortel
Lieven Annemans
Jean Paul Remon
Inge Van Tongelen
Guy Brusselle
A1
Journal Article
in
RESPIRATORY MEDICINE
2006
Outcome validation of a succinct HPV infection model for France
Lieven Annemans
C3
Conference
2006
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy - Implications for decision making
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2006
The impact of dose increase on the cost-effectiveness of statins
Lieven Annemans
C3
Conference
2006
Treatment of actinic keratosis (AK) and basal cell carcinoma (BCC) with Metvix (R) (MAL-pdt) in real life practice: A cost of illness and model validation study
Lieven Annemans
C3
Conference
2006
Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
2006
2005
A cost-effectiveness analysis of candesartan in the treatment of chronic heart failure
Lieven Annemans
C3
Conference
2005
A cost-effectiveness analysis of low-dose Aspirin in the primary prevention of cardiovascular disease in four European countries
Lieven Annemans
C3
Conference
2005
A cost-effectiveness model of escitalopram, citalopram, and venlafaxine as first-line treatment for major depressive disorder in Belgium
Lieven Annemans
A1
Journal Article
in
CLINICAL THERAPEUTICS
2005
A model-based cost-utility analysis of lyrica (TM)(pregabalin) versus current pharmaceutical management of peripheral neuropathic pain
Lieven Annemans
C3
Conference
2005
A multi-country health economic evaluation of N-3 polyunsaturated fatty acids (PUFA) in the secondary prevention after MI
Lieven Annemans
C3
Conference
2005
A pharmaco-economic evaluation of aggressive cholesterol lowering after acute coronary syndrome in Belgium: A short-term and long-term assessment
Lieven Annemans
C3
Conference
2005
A successful health education program to improve prevention in people with a family history of premature coronary heart disease
Lieve Debruyne
Stefaan De Henauw
Dirk De Bacquer
Lieven Annemans
Lea Maes
Gui De Backer
C1
Conference
2005
Aspirin in the primary prevention of cardiovascular disease - The health economic perspective
Lieven Annemans
C3
Conference
2005
Aspirin in the primary prevention of cardiovascular disease in Italian hypertensive patients - The health economic perspective
Lieven Annemans
C3
Conference
2005
Aspirin in the primary prevention of cardiovascular disease in hypertensive patients - The health economic perspective
Lieven Annemans
C3
Conference
2005
Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections
Stijn Blot
Pieter Depuydt
Lieven Annemans
Eric Hoste
Johan Decruyenaere
Dirk Vogelaers
Francis Colardyn
Koenraad Vandewoude
A1
Journal Article
in
CLINICAL INFECTIOUS DISEASES
2005
Cost drivers in multiple myeloma treatment - A 2 year analysis from a multicountry retroprojected chart review
Lieven Annemans
C3
Conference
2005
Cost effectiveness of long-acting risperidone: What can pharmacoeconomic models teach us?
Lieven Annemans
Editorial material
2005
Cost-effectiveness analysis of Aranesp (R) (darbepoetin alfa) administered once every three weeks compared to once every week
Lieven Annemans
C3
Conference
2005
Cost-effectiveness of everolimus vs mycophenolate mofetil (MMF) in de novo heart transplant recipients
Lieven Annemans
C3
Conference
2005
Diagnosis of fibromyalgia (FM) and healthcare resourse use in primary care in the United Kingdom
Lieven Annemans
C3
Conference
2005
Diagnosis of fibromyalgia and health care resource use in primary care in the UK
Lieven Annemans
C3
Conference
2005
Discounting health effects in pharmacoeconomic evaluations: Current controversies
Lieven Annemans
Editorial material
2005
Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients
Lieven Annemans
C3
Conference
2005
Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: An international perspective
Lieven Annemans
C3
Conference
2005
Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in Korea
Lieven Annemans
A1
Journal Article
in
INTERNATIONAL JOURNAL OF HEMATOLOGY
2005
Economic evaluation of intravenous itraconazole in presumed systemic fungal infections in neutropenic patients in Korea
Lieven Annemans
C3
Conference
2005
Economic evaluations in healthcare: comments on a recent article
Lieven Annemans
A1
Journal Article
in
REPRODUCTIVE BIOMEDICINE ONLINE
2005
Economic impact of hospital malnutrition
Lieven Annemans
C3
Conference
2005
Health economic evaluation based on the 5-year completed treatment analysis of the ATAC trial comparing anastrozole versus tamoxifen in adjuvant treatment of postmenopausal hormone receptor positive early breast cancer
Lieven Annemans
C3
Conference
2005
Health economic evaluation of bivalirudin in the management of patients undergoing percutaneous coronary intervention in Belgium
Lieven Annemans
C3
Conference
2005
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria
Lieven Annemans
A1
Journal Article
in
KIDNEY INTERNATIONAL
2005
Management of COPD in Belgium: A real life cost of illness study
Lieven Annemans
C3
Conference
2005
Modelling the clinical consequences of rimonabant in addition to diet and exercise in abdominally obese patients with type-2 diabetes
Lieven Annemans
C3
Conference
2005
The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis
Lieven Annemans
A1
Journal Article
in
BJU INTERNATIONAL
2005
The health economic value of Aspirin in the primary prevention of cardiovascular disease in diabetic patients in four European countries
Lieven Annemans
C3
Conference
2005
Thinking ahead: the rising tide of AIDS orphans
Wim Delva
Isabelle Dehaene
Sara Willems
Marleen Temmerman
Lieven Annemans
Editorial material
2005
2004
A health economic evaluation of 6 months alfuzosin treatment in the management of acute urinary retention
Lieven Annemans
C3
Conference
2004
A health economic evaluation of aspirin in the primary prevention of cardiovascular disease
Lieven Annemans
C3
Conference
2004
A health economic model to assess the long term effects and cost-effectiveness of PEG IFN alpha-2a in hepatitis C virus infected patients
Lieven Annemans
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2004
A real-life prospective health economic study of elective single embryo transfer versus two-embryo transfer in first IVF/ICSI cycles
Jan Gerris
Petra De Sutter
Lieven Annemans
Marc Dhont
A1
Journal Article
in
HUMAN REPRODUCTION
2004
An economic evaluation of clopidogrel vs. aspirin in secondary prevention of ischemic events in high risk atherothrombotic patients in Italy
Lieven Annemans
C3
Conference
2004
An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting
Lieven Annemans
A1
Journal Article
in
JOURNAL OF HUMAN HYPERTENSION
2004
Assessment of the economic value of the intercept blood system for platelets in Belgium
Lieven Annemans
C3
Conference
2004
Can we improve prevention in people with a family history of premature coronary heart disease?
Lieve Debruyne
Stefaan De Henauw
Dirk De Bacquer
Lieven Annemans
Lea Maes
Gui De Backer
C1
Conference
2004
Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium
Lieven Annemans
A1
Journal Article
in
ACTA CLINICA BELGICA
2004
Cost-efectiveness of irbesartan in type II diabetic nephropathy with hypertension. A spanish perspective
Lieven Annemans
A1
Journal Article
in
NEFROLOGIA
2004
Cost-effectiveness analysis of bicalutamide (Casodex((TM))) for adjuvant treatment of early prostate cancer
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2004
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertension medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease
Lieven Annemans
A1
Journal Article
in
DIABETES CARE
2004
Economic evaluation of intravenous itraconazole in presumed systemic fungal infections in neutropenic patients in Greece
Lieven Annemans
C3
Conference
2004
Education in pharmacoeconomics - An international multidisciplinary view
Lieven Annemans
A1
Journal Article
in
PHARMACOECONOMICS
2004
Evolution of prescriptions and drug costs in hypertension - Results from a database follow-up study
Lieven Annemans
C3
Conference
2004
Health economic consequences of irbesartan treatment of type 2 diabetes patients with nephropathy and hypertension in Germany
Lieven Annemans
A1
Journal Article
in
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
2004
Health economic evaluation of liver MRI in colorectal cancer patients
Lieven Annemans
A1
Journal Article
in
EUROPEAN RADIOLOGY
2004
Health economic evaluation of patients with rheumatoid arthritis (RA) treated with adalimumab
Lieven Annemans
C3
Conference
2004
Irbesartan is projected to be cost and life saving compared to standard blood pressure control alone fortreatment of patients with type 2 diabetes, hypertension, and microalbuminuria in Spanish, Swedish and Swiss settings
Lieven Annemans
C3
Conference
2004
Liposomal cytarabine (DepoCyte (TM) injection) is cost-effective compared with standard cytarabine for the intrathecal treatment of patients with lymphomatous meningitis
Lieven Annemans
C3
Conference
2004
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis
Lieven Annemans
A1
Journal Article
in
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
2004
Prospective assessment of the health and economic burden of neuropathic pain
Lieven Annemans
C3
Conference
2004
The cost-effectiveness of irbesartan in the treatment of hypertensive type 2 diabetic patients with microalbuminuria in China
Lieven Annemans
C3
Conference
2004
The cost-effectiveness of irbesartan in the treatment of hypertensive type 2 diabetic patients with microalbuminuria in Taiwan
Lieven Annemans
C3
Conference
2004
The efficacy of health education program to improve prevention in people with a family history of premature coronary heart disease (CHD)?
Lieve Debruyne
Stefaan De Henauw
Dirk De Bacquer
Lieven Annemans
Lea Maes
Gui De Backer
C3
Conference
2004
The perceived benefits of dosing schedules for children with ADHD
Sarah Dewilde
Lieven Annemans
C3
Conference
2004
Valuing prevention through economic evaluation - Some considerations regarding the choice of discount model for health effects with focus on infectious diseases
Lieven Annemans
Editorial material
2004
2003
An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings
Lieven Annemans
A1
Journal Article
in
NEPHROLOGY DIALYSIS TRANSPLANTATION
2003
Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries
Lieven Annemans
A1
Journal Article
in
LEUKEMIA & LYMPHOMA
2003
Irbesartan is projected to be cost and life saving in the French setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria
Lieven Annemans
C3
Conference
2003
Irbestartan is projected to be cost and life saving in the USA for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria
Lieven Annemans
C3
Conference
2003
Long-term medical costs of postmenopausal breast cancer therapy
Veronique Cocquyt
Lieven Annemans
Simon Van Belle
A1
Journal Article
in
ANNALS OF ONCOLOGY
2003
Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients
Lieven Annemans
A1
Journal Article
in
SUPPORTIVE CARE IN CANCER
2003
Postmenopausal breast cancer: incidence-based cost of illness
Veronique Cocquyt
Simon Van Belle
Lieven Annemans
A2
Journal Article
in
JOURNAL OF MEDICAL ECONOMICS
2003
2002
A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.
Lieven Annemans
A1
Journal Article
in
DIABETES CARE
2002
Analysis of resource use and costs associated with minor non-steroidal anti-inflammatory drugs (NSAID) related gastro-intestinal (GI) events. Poster presentation at the ISPOR 5th annual European Conference. Rotterdam 3-5/11/2002.
Lieven Annemans
C3
Conference
2002
Cost-effectiveness and budget impact of the sirolimus-eluting stent in the stent era. Podium presentation at the ISPOR 5th annual European Conference. Rotterdam 3-5/11/2002.
Lieven Annemans
C3
Conference
2002
Discontering van gezondheidswinst in farmaco-economische analyses
Lieven Annemans
Newsarticle
2002
Dringende geneeskundige hulpverlening
Lieven Annemans
Bookchapter
in
Handboek Gezondheidseconomie.
2002
Estimating cost-effectiveness of concerta oros in attention-deficit/hyperactivity disorder (ADHD) - Adapting the Canadian coordinating office for health technology assessment's (CCOHTA) economic model of methylphenidate immediate release versus behavioural interventions from a parent's perspective. Poster presentation at the ISPOR 5th annual European Conference. Rotterdam 3-5/11/2002.
Lieven Annemans
C3
Conference
2002
Modeling costs and cost-effectiveness of different CMV management strategies in liver transplant recipients as a support for current and future decision making
Lieven Annemans
A1
Journal Article
in
VALUE IN HEALTH
2002
Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium.
Lieven Annemans
A1
Journal Article
in
PHARMACY WORLD & SCIENCE
2002
Severe sepsis: clinical trial versus daily practice. A cost analysis in Belgium. Poster presentation at the ISPOR 5th annual European Conference. Rotterdam 3-5/11/2002.
Lieven Annemans
C3
Conference
2002
Study description and baseline results of the schizophrenia outcomes survey (SOS) observational study in Belgium. Poster presentation at the ISPOR 5th annual European Conference. Rotterdam 3-5/11/2002.
Lieven Annemans
C3
Conference
2002
The health-economic implications of the 'Irbesartan in diabetic nephropathy trial' (IDNT) in France and Belgium
Lieven Annemans
C3
Conference
2002
Toepassing van infliximab bij patiënten met de ziekte van Crohn: ervaringen bij 132 patiënten
Lieven Annemans
A2
Journal Article
in
NEDERLANDSCH TIJDSCHRIFT VOOR GENEESKUNDE
2002
Variation in medical resource utilisation in the management of pulmonary embolism in Belgium.
Lieven Annemans
Hugo Robays
A1
Journal Article
in
ACTA CLINICA BELGICA
2002
2001
Modeling the impact of a new oral anti-diabetic treatment on diabetes complication costs in France
Lieven Annemans
C1
Conference
2001
Orlistat in obese type 2 diabetic patients: assessment of long term outcomes and costeffectiveness
Lieven Annemans
C1
Conference
2001
Preventie van coronaire aandoeningen in België: kostprijs van statines
Lieven Annemans
Gui De Backer
Dirk De Bacquer
Stefaan De Henauw
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2001
1997
Pricing and reimbursement of pharmaceuticals in Belgium.
Lieven Annemans
Hugo Robays
A1
Journal Article
in
PHARMACOECONOMICS
1997
De kosten van twee behandelingen vergeleken: gemetastaseerd colorectaal carcinoom.
Lieven Annemans
[0-9]{2}
Inleiding tot de economische evaluatie van geneesmiddelen. Kluwer Handboek Gezondheidseconomie. Januari 2001.
Lieven Annemans
[0-9]{2}
Standard report format for economic evaluation of pharmaceuticals. Bespe-Pec 2000.
Lieven Annemans
[0-9]{2}